| RS2154550229 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS2154551556 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS2154551873 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS2154554705 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS2154555258 |
BRCA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary breast ovarian cancer syndrome, Breast-ovarian cancer |
| RS2154562860 |
CACNA1C
|
Health Risk |
Likely pathogenic |
Neurodevelopmental delay, Neurodevelopmental delay |
| RS2154562876 |
CACNA1C
|
Health Risk |
Conflicting classifications of pathogenicity |
Timothy syndrome, Timothy syndrome |
| RS2154562881 |
CACNA1C
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with hypotonia, language delay |
| RS2154565293 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS2154565302 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS2154565438 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS2154571835 |
CACNA1C
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome 8, Long QT syndrome 8 |
| RS2154576469 |
BRCA1
|
Health Risk |
Pathogenic |
Malignant tumor of breast, Breast-ovarian cancer |
| RS2154576881 |
BRCA1
|
Health Risk |
Pathogenic |
Malignant tumor of breast, Hereditary cancer-predisposing syndrome |
| RS2154577341 |
CACNA1C
|
Health Risk |
Likely pathogenic |
— |
| RS2154577345 |
CACNA1C
|
Health Risk |
Likely pathogenic |
Seizure, Seizure |
| RS2154577568 |
CACNA1C
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with hypotonia, language delay |
| RS2154578048 |
BRCA1
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2154580237 |
BRCA1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2154580433 |
PCDHGC4
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with poor growth and skeletal anomalies, Neurodevelopmental disorder with poor growth and skeletal anomalies |
| RS2154580601 |
PCDHGC4
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with poor growth and skeletal anomalies, Neurodevelopmental disorder with poor growth and skeletal anomalies |
| RS2154580803 |
PCDHGC4
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with poor growth and skeletal anomalies, Neurodevelopmental disorder with poor growth and skeletal anomalies |
| RS2154593437 |
CACNA1C
|
Health Risk |
Pathogenic |
Timothy syndrome, Timothy syndrome |
| RS2154596284 |
DIAPH1
|
Health Risk |
Pathogenic |
Autosomal dominant nonsyndromic hearing loss 1, Progressive microcephaly-seizures-cortical blindness-developmental delay syndrome |
| RS2154596304 |
DIAPH1
|
Health Risk |
Likely pathogenic |
Pendred syndrome, Pendred syndrome |
| RS2154596416 |
DIAPH1
|
Health Risk |
Likely pathogenic |
Autosomal dominant nonsyndromic hearing loss 1, Progressive microcephaly-seizures-cortical blindness-developmental delay syndrome |
| RS2154596448 |
DIAPH1
|
Health Risk |
Pathogenic |
Autosomal dominant nonsyndromic hearing loss 1, Progressive microcephaly-seizures-cortical blindness-developmental delay syndrome |
| RS2154596461 |
DIAPH1
|
Health Risk |
Pathogenic |
Autosomal dominant nonsyndromic hearing loss 1, Progressive microcephaly-seizures-cortical blindness-developmental delay syndrome |
| RS2154596613 |
DIAPH1
|
Health Risk |
Likely pathogenic |
Progressive microcephaly-seizures-cortical blindness-developmental delay syndrome, Autosomal dominant nonsyndromic hearing loss 1 |
| RS2154597562 |
DIAPH1
|
Health Risk |
Pathogenic |
Autosomal dominant nonsyndromic hearing loss 1, Progressive microcephaly-seizures-cortical blindness-developmental delay syndrome |
| RS2165241 |
LOXL1
|
Health Risk |
risk factor |
Exfoliation syndrome, susceptibility to |
| RS2205818 |
HAO1
|
Health Risk |
association |
Nephrolithiasis, calcium oxalate |
| RS2214326 |
DNAH11
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2219594 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Breast-ovarian cancer |
| RS2227434 |
FGB
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital afibrinogenemia, Congenital afibrinogenemia |
| RS2227606 |
SERPINC1
|
Health Risk |
Likely pathogenic |
Hereditary antithrombin deficiency, SERPINC1-related disorder |
| RS2227624 |
SERPINC1
|
Health Risk |
Pathogenic |
Hereditary antithrombin deficiency, Thromboembolism |
| RS2227863 |
SPTAN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 5 |
| RS2227871 |
ERCC5
|
Health Risk |
Conflicting classifications of pathogenicity |
Xeroderma pigmentosum, group G |
| RS2227872 |
BIVM-ERCC5;ERCC5
|
Health Risk |
Conflicting classifications of pathogenicity |
Xeroderma pigmentosum, group G |
| RS2227885 |
GJA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypoplastic left heart syndrome 1, Atrioventricular septal defect and common atrioventricular junction |
| RS2227922 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS2227943 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2227944 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, BRCA2-related cancer predisposition |
| RS2227945 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS2227954 |
CDK4
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial melanoma, Hereditary cancer-predisposing syndrome |
| RS2227956 |
HSPA1L
|
Health Risk |
association |
Chronic obstructive pulmonary disease, Chronic obstructive pulmonary disease |
| RS2228004 |
XPC
|
Health Risk |
Pathogenic |
— |
| RS2228106 |
TAP1
|
Health Risk |
Conflicting classifications of pathogenicity |
MHC class I deficiency, TAP1-related disorder |
| RS2228152 |
F8
|
Health Risk |
Pathogenic |
Hereditary factor VIII deficiency disease, Hereditary factor VIII deficiency disease |
| RS2228159 |
LIPA
|
Health Risk |
Conflicting classifications of pathogenicity |
Lysosomal acid lipase deficiency, Wolman disease |
| RS2228207 |
IGHMBP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive distal spinal muscular atrophy 1, Charcot-Marie-Tooth disease axonal type 2S |
| RS2228208 |
IGHMBP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive distal spinal muscular atrophy 1, Charcot-Marie-Tooth disease axonal type 2S |
| RS2228239 |
CIITA
|
Health Risk |
Conflicting classifications of pathogenicity |
MHC class II deficiency, MHC class II deficiency |
| RS2228271 |
EDNRB
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2228499 |
PYGL
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease, type VI |
| RS2228527 |
ERCC6
|
Health Risk |
Likely pathogenic |
Cockayne syndrome type 2, Cockayne syndrome type 2 |
| RS2228570 |
VDR
|
Health Risk |
Conflicting classifications of pathogenicity |
Vitamin D-dependent rickets type II with alopecia, Periodontitis |
| RS2228660 |
DARS1
|
Health Risk |
Conflicting classifications of pathogenicity |
DARS1-related disorder, DARS1-related disorder |
| RS2228671 |
LDLR
|
Health Risk |
Pathogenic |
Hypercholesterolemia, familial |
| RS2229000 |
KCNA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Episodic ataxia type 1, Episodic ataxia type 1 |
| RS2229008 |
KCNMA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Generalized epilepsy-paroxysmal dyskinesia syndrome, KCNMA1-related disorder |
| RS2229010 |
DAG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A9 |
| RS2229013 |
ANOS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypogonadotropic hypogonadism 1 with or without anosmia, Hypogonadotropic hypogonadism 1 with or without anosmia |
| RS2229019 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2229021 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS2229022 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS2229061 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Ovarian cancer, Hereditary nonpolyposis colorectal neoplasms |
| RS2229073 |
CBL
|
Health Risk |
Conflicting classifications of pathogenicity |
CBL-related disorder, RASopathy |
| RS2229141 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Central core myopathy, Malignant hyperthermia |
| RS2229149 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Malignant hyperthermia, susceptibility to |
| RS2229152 |
ACY1
|
Health Risk |
Conflicting classifications of pathogenicity |
Aminoacylase 1 deficiency, ACY1-related disorder |
| RS2229178 |
CA4
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2229194 |
CHRND
|
Health Risk |
Conflicting classifications of pathogenicity |
Lethal multiple pterygium syndrome, Congenital myasthenic syndrome |
| RS2229222 |
GAA
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease, type II |
| RS2229224 |
GAA
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease, type II |
| RS2229299 |
GTF2E2
|
Health Risk |
Conflicting classifications of pathogenicity |
GTF2E2-related disorder, GTF2E2-related disorder |
| RS2229311 |
IVD
|
Health Risk |
Likely pathogenic |
Isovaleryl-CoA dehydrogenase deficiency, IVD-related disorder |
| RS2229324 |
FBN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS2229331 |
HRG
|
Health Risk |
Conflicting classifications of pathogenicity |
HRG-related disorder, HRG-related disorder |
| RS2229413 |
CBS
|
Health Risk |
Conflicting classifications of pathogenicity |
HYPERHOMOCYSTEINEMIA, THROMBOTIC |
| RS2229483 |
HSPG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Schwartz-Jampel syndrome type 1, Schwartz-Jampel syndrome type 1 |
| RS2229487 |
HSPG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Lethal Kniest-like syndrome, Schwartz-Jampel syndrome |
| RS2229490 |
HSPG2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2229820 |
COL7A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Epidermolysis bullosa dystrophica, 7 conditions |
| RS2229843 |
TG
|
Health Risk |
Conflicting classifications of pathogenicity |
Iodotyrosyl coupling defect, Premature ovarian failure |
| RS2229860 |
RELN
|
Health Risk |
Conflicting classifications of pathogenicity |
Norman-Roberts syndrome, Familial temporal lobe epilepsy 7 |
| RS2229867 |
CNTN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Epilepsy, familial adult myoclonic |
| RS2229915 |
STX3
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS2229989 |
SOX9
|
Health Risk |
Conflicting classifications of pathogenicity |
Camptomelic dysplasia, Inborn genetic diseases |
| RS2229992 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS2229996 |
APC
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ovarian cancer |
| RS2230029 |
ABCB4
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive familial intrahepatic cholestasis type 3, Cholestasis |
| RS2230096 |
FOXC1
|
Health Risk |
Pathogenic |
Axenfeld-Rieger syndrome type 3, Axenfeld-Rieger syndrome type 3 |
| RS2230110 |
EP300
|
Health Risk |
Conflicting classifications of pathogenicity |
Rubinstein-Taybi syndrome due to EP300 haploinsufficiency, EP300-related disorder |
| RS2230180 |
ACADVL
|
Health Risk |
Conflicting classifications of pathogenicity |
Very long chain acyl-CoA dehydrogenase deficiency, Very long chain acyl-CoA dehydrogenase deficiency |
| RS2230210 |
C3
|
Health Risk |
Conflicting classifications of pathogenicity |
Age related macular degeneration 9, Complement component 3 deficiency |
| RS2230234 |
DSG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiomyopathy |
| RS2230288 |
GBA1
|
Health Risk |
Conflicting classifications of pathogenicity; risk factor |
Parkinsonian disorder, Rigidity |
| RS2230308 |
AGL
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease type III, Inborn genetic diseases |